These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10422304)

  • 21. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fat control--an effective antihypertensive strategy. Special recommendations for therapy of the overweight patient].
    Bönner G
    MMW Fortschr Med; 1999 Nov; 141(46):34-6. PubMed ID: 10795142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Salt sensitivity and hypertension].
    van Bommel EF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):240-4. PubMed ID: 12621978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.
    Toledo FG; Menshikova EV; Azuma K; Radiková Z; Kelley CA; Ritov VB; Kelley DE
    Diabetes; 2008 Apr; 57(4):987-94. PubMed ID: 18252894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effects of the short-term regular exercise-diet program on lipid profile in sedentary subjects].
    Yalin S; Gök H; Toksöz R
    Anadolu Kardiyol Derg; 2001 Sep; 1(3):179-8, AXV. PubMed ID: 12101821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obesity as a risk factor in the development of hypertensive organ damage].
    Hano T; Nishio I
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():87-91. PubMed ID: 15171347
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostics of disorders in lipid and carbohydrate metabolism in women with hypertension in outpatient clinic].
    Poliatykina TS; Al'-sveĭrki AD; Poltyrev BS; Romanenko IA; Budnikova NV; Mishina IE; Ivanova GV
    Ter Arkh; 2004; 76(1):22-5. PubMed ID: 15108431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the management of hypertension.
    Kaplan NM
    Can J Cardiol; 2000 Sep; 16(9):1147-52. PubMed ID: 11021958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New guidelines in hypertension. What is relevant for general practice?].
    Zidek W
    MMW Fortschr Med; 2001 May; 143(22):22-5. PubMed ID: 11460393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diet and arterial hypertension].
    Maldonado Simó ML
    Rev Enferm; 1998 Feb; 21(234 Suppl):13-6. PubMed ID: 9582854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.